Related Experiment Videos
[Substrate metabolism in untreated and treated thyrotoxicosis]
N Møller1, K Y Hove, S Nielsen
1Arhus Universitetshospital, Arhus Kommunehospital, medicinsk afdeling M.
Ugeskrift for Laeger
|April 1, 1998
Summary
Thyrotoxicosis accelerates metabolism, increasing protein and lipid oxidation, and glucose production. Treatment with methimazole normalizes these metabolic abnormalities, resolving hypermetabolism.
Area of Science:
- Endocrinology
- Metabolic Medicine
- Thyroid Research
Background:
- Accelerated metabolism is a key feature of thyrotoxicosis, but its biochemical underpinnings require further clarification.
- Understanding these metabolic changes is crucial for effective disease management and patient care.
Purpose of the Study:
- To investigate the biochemical mechanisms of accelerated metabolism in thyrotoxicosis.
- To assess the impact of methimazole treatment on metabolic parameters in patients with toxic goiter.
Main Methods:
- Studied 12 patients with newly diagnosed toxic goiter before and after methimazole treatment, compared to 11 healthy controls.
- Utilized indirect calorimetry, isotope dilution for glucose turnover, and forearm technique for muscle metabolism assessment.
- Measured thyroid hormones (T3), energy expenditure, substrate oxidation (protein, lipid), glucose production, and forearm blood flow.
Main Results:
- Untreated thyrotoxicosis showed increased T3 levels, resting energy expenditure, protein and lipid oxidation, endogenous glucose production, and non-oxidative glucose turnover.
- Muscle glucose oxidation and substrate exchange were unaffected by hyperthyroidism; propranolol did not alter thyroid hormones or energy expenditure.
- All measured metabolic abnormalities resolved following methimazole treatment.
Conclusions:
- Thyrotoxicosis augments the metabolism of all major fuel sources, contributing to hypermetabolism.
- Increased non-oxidative glucose metabolism may exacerbate thyrotoxicosis; these effects are reversible with medical treatment.